Pfizer, Merck KGaA’s Bavencio flunks study in hard-to-treat gastric cancer
The PD-L1 inhibitor Bavencio did not outperform chemo at extending patients’ lives in a major study in gastric cancer, raising questions about... Read More
Imugene welcomes receipt of US Department of Defense grant for City of Hope cancer researchers
City of Hope has received a $564,000 grant from the Department of Defense to study a cancer-fighting virus in the treatment of... Read More
Survival Outcomes of Gastric and Gastroesophageal Junction Adenocarcinomas Treated With Perioperative Chemotherapy ± Preoperative Radiotherapy
A new study of patients with early- and mid-stage gastric cancer found that those treated with chemo and radiation before surgery were... Read More
Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy
A study of the new drug Lonsurf in gastric cancer found that the treatment was tolerable and improved overall survival in patients... Read More
Resistance to antibiotics used to treat harmful stomach infection doubles in 20 years, new study finds
At United European Gastroenterology’s UEG Week in Barcelona, researchers presented a study of 1,232 patients that showed that resistance to clarithryomycin, which... Read More
Blood test detects more than 20 cancer types
A blood test being developed by Grail was able to detect more than 20 cancer types, including gastric and esophageal cancer, in... Read More
Better Short-Term Results With LADG in Stomach Cancer
A study found that patients who undergo minimally invasive laparoscopic gastrectomy are better able to tolerate chemotherapy for gastric cancer than are... Read More
Antibiotic use before cancer treatment cuts survival time study
Taking antibiotics in the month prior to starting immunotherapy for cancer can lessen the chance of survival, an important finding given the... Read More
PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2
Expression of the coding RNA PCAT-1 is associated with cisplatin resistance in gastric cancer, and suppressing PCAT-1 can re-sensitize cancer cells to... Read More
Deciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors
Deciphera Pharmaceuticals announced positive results from a phase 3 study of Repretinib in gastrointestinal stromal tumors.
